The researchers reported no conflicts of interest
The choice between injection and oral depends on your comfort level, lifestyle preferences, and how quickly you want to see resultsboth are evidence-based options with strong clinical support
2 Tirzepatide Proves Cardiovascular Superiority (SURPASS-CVOT) Presented at #ACC26, a head-to-head analysis against the mono-agonist dulaglutide showed that tirzepatide was associated with a 16% lower risk of a composite cardiorenal endpoint (heart attack, stroke, death, and kidney failure)
Normally, advice is to swap white, starchy carbohydrates for high-fibre, brown complex carbohydrates to manage appetite regulation, promote gut health and manage energy levels
Even modest weight loss can significantly improve your quality of life